◀ Back to MED1
MED1 — MMP9
Text-mined interactions from Literome
Stephenson et al., The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2005
(Fetal Membranes, Premature Rupture) :
TRAP-14 , a thrombin receptor agonist, also significantly
increased MMP-9 levels, suggesting that thrombin induced changes in MMP-9 expression were mediated through the thrombin receptor
Franco et al., Exp Cell Res 2011
(Bone Resorption) :
Furthermore,
MMP-9 enzyme inhibitor also
attenuated both RANKL induced osteoclastogenesis and up-regulation of
TRAP and cathepsin K mRNA expression, indicating that MMP-9 enzyme action is engaged in the promotion of RANKL induced osteoclastogenesis